<DOC>
<DOCNO>EP-0611766</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Polysubstituted 2-amido thiazoles derivatives, process for their preparation, pharmaceutical compositions and utilization for the preparation of a medicament.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31403	A61K31404	A61K31425	A61K31425	A61K31427	A61K31427	A61K3144	A61K3144	A61K3147	A61K3147	A61K314709	A61K314709	A61K31505	A61K31505	A61P100	A61P100	A61P300	A61P308	A61P2500	A61P2500	A61P2518	C07D27700	C07D27740	C07D41700	C07D41704	C07D41712	C07D41714	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P1	A61P1	A61P3	A61P3	A61P25	A61P25	A61P25	C07D277	C07D277	C07D417	C07D417	C07D417	C07D417	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The subject of the invention is the use of a compound of formula 
<
IMAGE
>
 in which Y represents a 3-quinolyl group or a 2-indolyl group of formula: 
<
IMAGE
>
  in which:   - R is hydrogen, an acetyl group or a CH2COOR' group, R' being hydrogen or a C1-C4 alkyl; - X is a (hetero)aryl radical chosen from 4-chloro-2,6-dimethoxyphenyl, 2,6-dimethoxy-4-methylphenyl, 2,4,5-trimethoxyphenyl, 4-methyl-2,3,6-trimethoxyphenyl, 2,6-dimethoxy-4-ethylphenhyl, 2,4,6-trimethoxy-5-chlorophenyl, 2,4,6-trimethoxy-3-pyridyl, 2,4-dimethoxy-6-methyl-3-pyridyl, 6-chloro-2,4-dimethoxy-5-pyrimidrimyl, 2,4,6-trimethoxy-5-pyinidinyl, 5-chloro-2,4-dimethoxyphenyl, 5-chloro-2-methoxy-4-methylphenyl, 2,5-dimethoxy-4-methylphenyl, 4-trifluoromethyl-2,6-dimethoxyphenyl, 2,4-dimethoxy-5-methylphenyl, 5-ethyl-2,4-dimethoxyphenyl or 2,4-dimethoxyphenyl groups;   - Z represents H, a C1-C4 alkyl or a benzyl; with the restriction that Z is necessarily hydrogen when X is a phenyl radical simultaneously substituted in the 2- and 6-positions or when X is a 3-pyridyl radical simultaneously substituted in the 2- and 4-positions or when X is a 5-pyrimidinyl radical simultaneously substituted in the 4- and 6-positions.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
SANOFI ELF
</APPLICANT-NAME>
<APPLICANT-NAME>
ELF SANOFI
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BOIGEGRAIN ROBERT
</INVENTOR-NAME>
<INVENTOR-NAME>
BRODIN ROGER
</INVENTOR-NAME>
<INVENTOR-NAME>
FREHEL DANIEL
</INVENTOR-NAME>
<INVENTOR-NAME>
GULLY DANIELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
MOLIMARD JEAN-CHARLES
</INVENTOR-NAME>
<INVENTOR-NAME>
OLLIERO DOMINIQUE
</INVENTOR-NAME>
<INVENTOR-NAME>
BOIGEGRAIN, ROBERT
</INVENTOR-NAME>
<INVENTOR-NAME>
BRODIN, ROGER
</INVENTOR-NAME>
<INVENTOR-NAME>
FREHEL, DANIEL
</INVENTOR-NAME>
<INVENTOR-NAME>
GULLY, DANIELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
MOLIMARD, JEAN-CHARLES
</INVENTOR-NAME>
<INVENTOR-NAME>
OLLIERO, DOMINIQUE
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
